Articles in Scholarly Journals [Incomplete List]

1. Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom
   Sarcoma, vol. 2007, Article ID 34128, 6 pages, 2007
2. Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data
   Clinical Trials, vol. 4, no. 2, pp. 154–161, 2007
3. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
   British Journal of Cancer, vol. 94, no. 2, Article ID 6602923, 5 pages, 2006
4. Identification of serum biomarkers for colon cancer by proteomic analysis
   British Journal of Cancer, vol. 94, no. 12, Article ID 6603188, 7 pages, 2006
5. Environmental Science & Technology, vol. 40, no. 12, pp. 4031–4036, 2006
6. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
   Journal of Experimental Medicine, vol. 202, no. 3, pp. 379–386, 2005
7. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial
   European Heart Journal, vol. 26, no. 24, pp. 2681–2688, 2005
8. Cost effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial: reply
   European Heart Journal, vol. 27, no. 9, pp. 1125–1126, 2005
9. Clinical trial design in hepatocellular carcinoma
   Best Practice & Research Clinical Gastroenterology, vol. 19, no. 1, pp. 119–127, 2005
10. An open letter to all members of the IASLC
    Lung Cancer, vol. 45, no. 1, pp. 119–120, 2004
11. To the Editor
    Radiotherapy and Oncology, vol. 68, no. 1, pp. 89–90, 2003
12. The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease
    Annals of Oncology, vol. 14, no. 2, pp. 282–290, 2003
13. Potential hazards in the analysis of symptom improvement
    Lung Cancer, vol. 40, no. 2, pp. 201–202, 2003
14. Simultaneous analysis of quality of life and survival data
    Statistical Methods in Medical Research, vol. 11, no. 1, pp. 25–48, 2002
15. Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer
    Lung Cancer, vol. 37, no. 2, pp. 219–225, 2002
16. Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease
    British Journal of Haematology, vol. 118, no. 1, pp. 195–201, 2002
17. Retrospective study of acute toxicity following short-course preoperative radiotherapy
    British Journal of Surgery, vol. 89, no. 7, pp. 889–895, 2002
18. Annals of Oncology, vol. 12, no. 12, pp. 1671–1675, 2001
19. Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.
    Journal of Clinical Pathology, vol. 50, no. 8, pp. 640–644, 1997
20. Tumour heterogeneity: a problem in biopsy assessment of the proliferation index of oesophageal adenocarcinomas
    Molecular Pathology, vol. 49, no. 1, pp. M61–M63, 1996